Want to see BBOT full AI Analyst Report?
Technical Sentiment
Overall Consensus
Strong Sell
5Bullish
1Neutral
16Bearish
Technical Analysis Consensus
Neutral
5Bullish
1Neutral
4Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
BridgeBio Oncology Therapeutics’s (BBOT) Moving Averages Convergence Divergence (MACD) indicator is -1.07, suggesting BridgeBio Oncology Therapeutics is a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 20-Day exponential moving average is 4.80, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $9.37, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 50-Day exponential moving average is 6.35, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $9.37, making it a Sell.
BridgeBio Oncology Therapeutics (BBOT) Pivot Points
Classic
3.19
3.38
3.49
3.69
3.80
3.99
4.10
Fibonacci
3.38
3.50
3.57
3.69
3.80
3.87
3.99
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
BridgeBio Oncology Therapeutics (BBOT) Moving Averages
MA5
3.81Sell
3.73Sell
MA10
3.89Sell
4.02Sell
MA20
4.49Sell
4.80Sell
MA50
7.16Sell
6.35Sell
MA100
7.70Sell
7.43Sell
MA200
8.98Sell
8.90Sell
BridgeBio Oncology Therapeutics’s (BBOT) 10-Day exponential moving average is 4.02, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $9.37, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 100-Day exponential moving average is 7.43, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $9.37, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $9.37 and BridgeBio Oncology Therapeutics’s (BBOT) 50-day simple moving average is 7.16, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $9.37 and BridgeBio Oncology Therapeutics’s (BBOT) 100-day simple moving average is 7.70, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $9.37 and BridgeBio Oncology Therapeutics’s (BBOT) 200-day simple moving average is 8.98, creating a Sell signal.
BridgeBio Oncology Therapeutics (BBOT) Technical Indicators
RSI (14)
18.12
Buy
STOCH (9,6)
4.97
Buy
STOCHRSI (14)
3.50
Buy
MACD (12,26)
-1.07
Sell
ADX (14)
55.20
Sell
Williams %R
-98.77
Buy
CCI (14)
-103.00
Buy
ATR (14)
0.38
-
Ultimate Oscillator
31.72
Neutral
ROC
-26.47
Sell
BridgeBio Oncology Therapeutics’s (BBOT) Relative Strength Index (RSI) is 18.12, creating a Buy signal.
BridgeBio Oncology Therapeutics’s (BBOT) Trend Strength Indicator (ADX) is 55.20, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) Commodity Channel Index (CCI) is -103.00, creating a Buy signal.
BridgeBio Oncology Therapeutics’s (BBOT) Price Rate of Change (ROC) is -26.47, creating a Sell signal.
FAQ
Is BBOT a Buy, Hold, or Sell?
Based on BBOT’s technical indicators, BBOT is a Strong Sell.
What is BBOT’s RSI (14)?
BBOT’s RSI (14) is 18.12, which suggests BBOT is a Buy.
What is BBOT’s MACD?
BBOT’s MACD is -1.07, which suggests BBOT is a Sell.
What is BBOT’s 5-day moving average?
BBOT’s 5-day moving average is 3.81, which suggests BBOT is a Sell.
What is BBOT’s 20-day moving average?
BBOT 20-day moving average is 4.49, which suggests BBOT is a Sell.
What is BBOT’s 50-day moving average?
BBOT’s 50-day moving average is 7.16, which suggests BBOT is a Sell.
What is BBOT’s 200-day moving average?
BBOT’s 200-day moving average is 8.98, which suggests BBOT is a Sell.
What is BBOT’s Williams % R (14)?
BBOT’s Williams % R (14) is -98.77, which suggests BBOT is a Buy.
What is BBOT’s CCI (14)?
BBOT’s CCI (14) is -103.00, which suggests BBOT is a Buy.